Variation name (cDNA level) | Variation name (protein level) | Variation status | Variation class |
c.IVS36+3insT (c.4582+3insT) | Heterozygous | Mutation |
wt codon | wt aa | mutant codon | mutant aa | mutational event | mutation type |
GAT | Asp | spl+3 | Spl. | insT | Tv |
Structure | Key Residue (HCD) | Pyrimidin doublet | CpG |
TGFBP#04 | conserved AA in TGFBP |
At the mRNA level | On restriction map |
Skipping of exon 36, in phase | New restriction site(s): none Lost restriction site(s): none |
Impact on splicing | ||||||||||
Splice site type | Wild type sequence | CV | Mutant type sequence | CV | Variation (%) | |||||
TTGgtaaga |
| TTGgttaag |
| -26.8 % |
Sample ID | Patient status | Gender | Transmission | Age of onset | Age of death | Geographic origin |
USA09FAR F0005 I01 | Proband | Male | de novo | U.S.A. |
Phenotypic group | Disease |
NA | MFS |
Symptom | Severity | Age |
C-Asc. aortic dilatation | 29 | |
O-Ectopia lentis | bilateral | 29 |
S-Arachnodactyly (M) | 29 | |
S-Dolichostenomelia | 29 |
Reference ID | PubMed ID | Reference |
210 | 11251996 | Toudjarska I, Kilpatrick MW, Lembessis P, Carra S, Harton GL, Sisson ME, Black SH, Stern HJ, Gelman-Kohan Z, Shohat M, Tsipouras P. "Novel approach to the molecular diagnosis of Marfan syndrome: application to sporadic cases and in prenatal diagnosis". Am J Med Genet. 2001 Apr 1;99(4):294-302. |